{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"primary-biliary-cholangitis-primary-sclerosing-cholangitis-and-autoimmune-hepatitis-overlap","columns":[{"gene":"","key":"population-fd7016356ef42862db83","label":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","mondoId":"MONDO:0034189","onsetQualifier":null,"originColumnKey":"MONDO:0034189/ORPHA:562639","originalViews":[{"key":"MONDO:0034189/ORPHA:562639","label":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","scopeLabel":"ORPHA:562639","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0c9584ad437e19368865d8dad2a13494d9aec61ffb69991442f3a4131e2e721f","14f9f83918b32ac97cf82a7335402eed981f7048508ba1646fbdac7c1f060ea4","150a4899785df1d936fdb2aa48dc47af3b392314dfa92e84bea3ba06599ee76f","2079744c913d4f7ae9629c486031504369fd829fa65af10036154e3b415bbbd4","2c288b0528f6a87c6034adbc368917dffbf23da3abac1e26f1238d6ac9bdc12b","2da46d6fee8d202a540fa7b83766f7ebcede6b7463652447dbb1ee2774713d1d","2f270a2ef231a95f4a383dff4dfad5df192ca40db95d1bb1acdba3c534637dfe","37d0f029bd1e38e45aaa6e69cb1a3ce94bb20f83aa8a25426babb3ecfdf9c6cb","3b319e414b91dfc3fa5e8d583c6d7cdff257f76f7775bf98998564fa63d40504","44b8db4f31a6de6eab744641080e3b70ad3a7f8bef514855fc3edbd9321a4136","4853b0043c19a2350e5e93bf4b4aa110e3f67eb59dedde98a719bc06d2a1b242","4dead107a60eb8bfb3eae19a780d442f3661aef72f477ec16feb783a3e20df97","59c3a6cfde528294fcbcfbd5a86ddcc566e7a197ead8176aa5245936b551cec7","5a8442e472097f7ab92e39762e41ecfcc68cef33be3f07feea94641d6cbbc2c1","5db39d1c994b7675f524a968de9b84991267b904795851d92510fd168d95e055","63c942946a628d548f826d123124ab832231db9dbb9f7c6a6cdca452173f3d38","6b18d32e191b995ead877533345e26e12f78f515c415fb5b44710040c35e2113","6b220741916eb3b2dbf71d0ba4f5c31f1a4067f30f130498435c8c7b3c274afd","6d258a88b7f32935ad116c283e0179e0ffea78df9a99379a43bee4ea683a9a38","7e78a916a8b01db7fe16a925fe7d7b31fac9b1eecc98f0e183431042aebdc30d","80bdc1b8f446481a3c934707457c87c9fa2083b4b792be9250ccd6a22e32be4b","86e377628e984d4d19fb2e16d1f4c832020dd615ce8d6fb13a34652b12390569","8b9cfa6a8bab4ccbc6eba03cbdd215e971f75362c70e4ed49ceabab59baf9a73","94d55050e2eb35508cdc854cfd55c91759e0d9364870809cd3cf43999ac7c675","967b1283de4291609130ebee8750fb3d2efd72ca4b7edfc0ff7c208b7deb344c","98d68cdf237e3f8ffa0d6d4b535ed35e7910d9e707b1fb027fc34437f27e1a2b","99d99abac68a41d0fa2052e1a576442f13d26839844fa360b57b29e97ae78baf","a5f8bb2666e8251096f17192bec0db1a6f26c4c6ec35e2c1d1c22e74276cbd4d","aa7831307c18a28acab804367c416072057de9bcd78d13da08bdc956ec17b2c0","af887d29e17dbf8c31819f71485f67ead8ca2a8438ec97f982299cfc08114547","c3a38b686fde37c1f9fa2e2743284f2fd62fc18b570064883bda571479192b00","d03bf004f0dc1383a51e2524511da0b4025d5d36ea21dd80b0b9b221d314b227","dfe6503faf2b61e379e491e3f7da312c24338fe2fef95ea2970504f6f1fba836","e2615a02df1feb82f58adc5a041b2336f16dd9dee1f55984e91d5d5b9bf0c905","f55082bb7d4300e275803b2ec17db6701bb665a7c9a91ed7176aa1fe3769b993","f7dafd1585173e4be2d25449cb5fefcad1ccf768386219f7d139942f27148e72"],"recordQualifiers":{},"scopeLabel":"ORPHA:562639","sourceIds":["ORPHA:562639"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-fd7016356ef42862db83"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0100889","HP:0011040","HP:0034110","HP:0033562","HP:0034114","HP:0034115","HP:0030909"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":36,"sourceGroups":{"orphanet":36}},"features":[{"hpoId":"HP:0100889","label":"Abnormal ductus choledochus morphology","primary":true},{"hpoId":"HP:0011040","label":"Abnormal intrahepatic bile duct morphology","primary":true},{"hpoId":"HP:0034110","label":"Anti-Gerbich phenotype 1 antibody positivity","primary":true},{"hpoId":"HP:0033562","label":"Anti-glycoprotein-210 antibody positivity","primary":true},{"hpoId":"HP:0034114","label":"Anti-hexokinase-1 antibody positivity","primary":true},{"hpoId":"HP:0034115","label":"Anti-Kelch like protein 12 antibody positivity","primary":true},{"hpoId":"HP:0030909","label":"Anti-liver cytosolic antigen type 1 antibody positivity","primary":true},{"hpoId":"HP:0034111","label":"Anti-MIT3 antibody positivity","primary":false},{"hpoId":"HP:0034107","label":"Anti-p53 antibody positivity","primary":false},{"hpoId":"HP:0034093","label":"Anti-Ro52/TRIM21 antibody positivity","primary":false},{"hpoId":"HP:0003262","label":"Anti-smooth muscle antibody positivity","primary":false},{"hpoId":"HP:0034155","label":"Anti-sp100 antibody positivity","primary":false},{"hpoId":"HP:0034108","label":"Anti-Y-box protein-1 antibody positivity","primary":false},{"hpoId":"HP:0030167","label":"Antimitochondrial antibody positivity","primary":false},{"hpoId":"HP:0003493","label":"Antinuclear antibody positivity","primary":false},{"hpoId":"HP:0002829","label":"Arthralgia","primary":false},{"hpoId":"HP:0030057","label":"Autoimmune antibody positivity","primary":false},{"hpoId":"HP:0001396","label":"Cholestasis","primary":false},{"hpoId":"HP:0002611","label":"Cholestatic liver disease","primary":false},{"hpoId":"HP:0001394","label":"Cirrhosis","primary":false},{"hpoId":"HP:0003155","label":"Elevated circulating alkaline phosphatase concentration","primary":false},{"hpoId":"HP:0002910","label":"Elevated circulating hepatic transaminase concentration","primary":false},{"hpoId":"HP:0030948","label":"Elevated gamma-glutamyltransferase level","primary":false},{"hpoId":"HP:0012378","label":"Fatigue","primary":false},{"hpoId":"HP:0032252","label":"Granuloma","primary":false},{"hpoId":"HP:0030988","label":"Granulomatous cholangitis","primary":false},{"hpoId":"HP:0002904","label":"Hyperbilirubinemia","primary":false},{"hpoId":"HP:0003237","label":"Increased circulating IgG concentration","primary":false},{"hpoId":"HP:0003496","label":"Increased circulating IgM concentration","primary":false},{"hpoId":"HP:0002037","label":"Inflammation of the large intestine","primary":false},{"hpoId":"HP:0032220","label":"Interface hepatitis","primary":false},{"hpoId":"HP:0025344","label":"Interlobular bile duct destruction","primary":false},{"hpoId":"HP:0030908","label":"Liver kidney microsome type 1 antibody positivity","primary":false},{"hpoId":"HP:0000989","label":"Pruritus","primary":false},{"hpoId":"HP:0030991","label":"Sclerosing cholangitis","primary":false},{"hpoId":"HP:0100279","label":"Ulcerative colitis","primary":false}],"ledeHtml":"","mondoId":"MONDO:0034189","node":{"canonicalSlug":"primary-biliary-cholangitis-primary-sclerosing-cholangitis-and-autoimmune-hepatitis-overlap","comparisons":[{"documentSha256":"429b53e1e54bbd24cfd9dfada9938bb78f2819a04c43ceaa6b1c082b480e37b4","key":"legacy-autoimmune-hepatitis","kind":"legacy","label":"autoimmune hepatitis","memberIds":["MONDO:0016264","MONDO:0034189"],"mondoId":"MONDO:0016264","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/autoimmune-hepatitis.429b53e1e54bbd24cfd9dfada9938bb78f2819a04c43ceaa6b1c082b480e37b4.json"}],"contexts":[],"lifecycle":"active","narrative":null,"ownColumnKeys":["population-fd7016356ef42862db83"],"publication":"published","relationships":[{"kind":"parent","label":"cholangitis","mondoId":"MONDO:0004789","slug":null},{"kind":"parent","label":"autoimmune hepatitis","mondoId":"MONDO:0016264","slug":"autoimmune-hepatitis"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/22250"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0c9584ad437e19368865d8dad2a13494d9aec61ffb69991442f3a4131e2e721f","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003493","is_excluded":false,"label":"Antinuclear antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"14f9f83918b32ac97cf82a7335402eed981f7048508ba1646fbdac7c1f060ea4","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000989","is_excluded":false,"label":"Pruritus","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"150a4899785df1d936fdb2aa48dc47af3b392314dfa92e84bea3ba06599ee76f","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2079744c913d4f7ae9629c486031504369fd829fa65af10036154e3b415bbbd4","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011040","is_excluded":false,"label":"Abnormal intrahepatic bile duct morphology","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2c288b0528f6a87c6034adbc368917dffbf23da3abac1e26f1238d6ac9bdc12b","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030988","is_excluded":false,"label":"Granulomatous cholangitis","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2da46d6fee8d202a540fa7b83766f7ebcede6b7463652447dbb1ee2774713d1d","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0032220","is_excluded":false,"label":"Interface hepatitis","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2f270a2ef231a95f4a383dff4dfad5df192ca40db95d1bb1acdba3c534637dfe","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001396","is_excluded":false,"label":"Cholestasis","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"37d0f029bd1e38e45aaa6e69cb1a3ce94bb20f83aa8a25426babb3ecfdf9c6cb","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034114","is_excluded":false,"label":"Anti-hexokinase-1 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b319e414b91dfc3fa5e8d583c6d7cdff257f76f7775bf98998564fa63d40504","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002910","is_excluded":false,"label":"Elevated circulating hepatic transaminase concentration","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"44b8db4f31a6de6eab744641080e3b70ad3a7f8bef514855fc3edbd9321a4136","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034107","is_excluded":false,"label":"Anti-p53 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4853b0043c19a2350e5e93bf4b4aa110e3f67eb59dedde98a719bc06d2a1b242","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002829","is_excluded":false,"label":"Arthralgia","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4dead107a60eb8bfb3eae19a780d442f3661aef72f477ec16feb783a3e20df97","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002037","is_excluded":false,"label":"Inflammation of the large intestine","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"59c3a6cfde528294fcbcfbd5a86ddcc566e7a197ead8176aa5245936b551cec7","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001394","is_excluded":false,"label":"Cirrhosis","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5a8442e472097f7ab92e39762e41ecfcc68cef33be3f07feea94641d6cbbc2c1","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002611","is_excluded":false,"label":"Cholestatic liver disease","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5db39d1c994b7675f524a968de9b84991267b904795851d92510fd168d95e055","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030057","is_excluded":false,"label":"Autoimmune antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"63c942946a628d548f826d123124ab832231db9dbb9f7c6a6cdca452173f3d38","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034108","is_excluded":false,"label":"Anti-Y-box protein-1 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6b18d32e191b995ead877533345e26e12f78f515c415fb5b44710040c35e2113","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034155","is_excluded":false,"label":"Anti-sp100 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6b220741916eb3b2dbf71d0ba4f5c31f1a4067f30f130498435c8c7b3c274afd","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025344","is_excluded":false,"label":"Interlobular bile duct destruction","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6d258a88b7f32935ad116c283e0179e0ffea78df9a99379a43bee4ea683a9a38","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003155","is_excluded":false,"label":"Elevated circulating alkaline phosphatase concentration","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7e78a916a8b01db7fe16a925fe7d7b31fac9b1eecc98f0e183431042aebdc30d","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034115","is_excluded":false,"label":"Anti-Kelch like protein 12 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"80bdc1b8f446481a3c934707457c87c9fa2083b4b792be9250ccd6a22e32be4b","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003262","is_excluded":false,"label":"Anti-smooth muscle antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"86e377628e984d4d19fb2e16d1f4c832020dd615ce8d6fb13a34652b12390569","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002904","is_excluded":false,"label":"Hyperbilirubinemia","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8b9cfa6a8bab4ccbc6eba03cbdd215e971f75362c70e4ed49ceabab59baf9a73","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030948","is_excluded":false,"label":"Elevated gamma-glutamyltransferase level","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"94d55050e2eb35508cdc854cfd55c91759e0d9364870809cd3cf43999ac7c675","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0030908","is_excluded":false,"label":"Liver kidney microsome type 1 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"967b1283de4291609130ebee8750fb3d2efd72ca4b7edfc0ff7c208b7deb344c","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034093","is_excluded":false,"label":"Anti-Ro52/TRIM21 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"98d68cdf237e3f8ffa0d6d4b535ed35e7910d9e707b1fb027fc34437f27e1a2b","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034111","is_excluded":false,"label":"Anti-MIT3 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"99d99abac68a41d0fa2052e1a576442f13d26839844fa360b57b29e97ae78baf","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003237","is_excluded":false,"label":"Increased circulating IgG concentration","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a5f8bb2666e8251096f17192bec0db1a6f26c4c6ec35e2c1d1c22e74276cbd4d","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003496","is_excluded":false,"label":"Increased circulating IgM concentration","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aa7831307c18a28acab804367c416072057de9bcd78d13da08bdc956ec17b2c0","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100279","is_excluded":false,"label":"Ulcerative colitis","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"af887d29e17dbf8c31819f71485f67ead8ca2a8438ec97f982299cfc08114547","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0033562","is_excluded":false,"label":"Anti-glycoprotein-210 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c3a38b686fde37c1f9fa2e2743284f2fd62fc18b570064883bda571479192b00","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030167","is_excluded":false,"label":"Antimitochondrial antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d03bf004f0dc1383a51e2524511da0b4025d5d36ea21dd80b0b9b221d314b227","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100889","is_excluded":false,"label":"Abnormal ductus choledochus morphology","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dfe6503faf2b61e379e491e3f7da312c24338fe2fef95ea2970504f6f1fba836","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030991","is_excluded":false,"label":"Sclerosing cholangitis","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e2615a02df1feb82f58adc5a041b2336f16dd9dee1f55984e91d5d5b9bf0c905","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030909","is_excluded":false,"label":"Anti-liver cytosolic antigen type 1 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f55082bb7d4300e275803b2ec17db6701bb665a7c9a91ed7176aa1fe3769b993","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0032252","is_excluded":false,"label":"Granuloma","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f7dafd1585173e4be2d25449cb5fefcad1ccf768386219f7d139942f27148e72","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:562639","disease_name":"Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0034110","is_excluded":false,"label":"Anti-Gerbich phenotype 1 antibody positivity","onset_id":null,"reference":"ORPHA:562639","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[],"sharedSources":[],"slug":"primary-biliary-cholangitis-primary-sclerosing-cholangitis-and-autoimmune-hepatitis-overlap","sourceDocuments":[],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome"},"schemaVersion":1}
